NEI Research News

A new study projects that nearly half of all adult Hispanic/Latino individuals in the United States with diabetes have some type of diabetic retinopathy, a degenerative disease affecting vision.

Eye drops that reduce elevated pressure inside the eye can delay or possibly prevent the onset of glaucoma in African Americans at higher risk for developing the disease, researchers have found.

A new study reports that Hispanic/Latino individuals in the United States have higher rates of visual impairment and blindness than members of other ethnic groups.

With the aging of the population, the number of Americans with major eye diseases is increasing, and vision loss is becoming a major public health problem. By the year 2020, the number of people who are blind or have low vision is projected to increase su

Results from the first phase of the Vision in Preschoolers (VIP) study were published in the April 2004 issue of the journal Ophthalmology.

A preliminary clinical trial, conducted by researchers at the National Institutes of Health (NIH), found that an investigational treatment for uveitis seems to have many fewer side effects than existing therapies

The National Eye Institute (NEI), a part of the Federal government’s National Institutes of Health, recently published its latest planning document, National Plan for Eye and Vision Research. 

An important clinical trial, sponsored by the National Eye Institute(NEI), a part of the National Institutes of Health (NIH), has provided doctors with improved prognostic indicators and treatment options for retinopathy of prematurity.

Prescribing six hours of daily patching for the unaffected eye of children with severe amblyopia works as well as prescribing full-time patching.

Patching the unaffected eye of children with moderate amblyopia for two hours daily works as well as patching the eye for six hours.